Antoine Prestat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antoine prestat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antoine Prestat Today - Breaking & Trending Today

PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers

PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France General , United Kingdom , Czech Republic , United States , Fondation Fournier Majoie , Laboratoires Fournier , Institut Curie , Gustave Roussy , Christophe Le Tourneau , Marie Curie , Antoine Prestat , Marie Puvieux , Centre Fran , Sorbonne University , Head Of The Department Drug Development , Carnot Curie Cancer Institute , Seed Fund , Institut Curie Announce First Patients Dosed , Phase Ib Clinical Trial Evaluating , Institut Curie Announce First Patients , Institut De Canc , Medical Oncologist , Drug Development , Principal Investigator , Molecular Targets , Cancer Therapeutics ,

PEP-Therapy and Institut Curie initiate dosing in solid tumour trial

PEP-Therapy and Institut Curie initiate dosing in solid tumour trial
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Antoine Prestat , Gustave Roussy , Institut Curie , Baclesse Center , Cell Penetrating , Interfering Peptides ,

PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors

/PRNewswire/ PEP-Therapy, a clinical-stage biotechnology company developing cell penetrating peptides as targeted therapies in oncology, and Institut Curie,. ....

Czech Republic , France General , Marie Curie , Bernard Majoie , Sylvie Berrebi , Laboratoires Fournier , Christophe Le Tourneau , Gustave Roussy , Antoine Prestat , Institut Curie , Seed Fund , Head Of The Department Drug Development , Sorbonne University , Fournier Majoie Foundation For Innovation , Baclesse Center , Cell Penetrating , Interfering Peptides , Professor Christophe Le Tourneau , Medical Oncologist , Drug Development , Principal Investigator , Triple Negative Breast Cancer , Ovarian Cancer , Maximum Tolerated Dose , Italian Angels , Magna Capital Partners ,

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010

as well as a €1 million loan from Bpifrance
PARIS, July 19, 2021 /PRNewswire/
PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of cancers, announced today that it raised an additional €2.6 million ($3 million) in an extension of its Series A financing round, bringing the total raised in this round to €5.4 million ($6.4 million). This new funding comprises €1.6 million in equity from Anaxago, i&i Prague and BADGE as well as a €1 million loan from Bpifrance.
This increased financial support highlights the potential of PEP-010, as well as PEP-Therapy s Cell Penetrating & Interfering Peptide (CP&IP) technology platform, which was first developed at Sorbonne University and Institut Curie. ....

Czech Republic , France General , Laboratoires Fournier , Bernard Majoie , Antoine Prestat , Gustave Roussy , Sylvie Berrebi , Institut Curie , Gaston Vasseur , Seed Fund , Sorbonne University , Fournier Majoie Foundation For Innovation , Bpifrance This , Cell Penetrating , Interfering Peptide , Investment Manager , Fonds Unique Interminist , Interfering Peptides , Italian Angels , Magna Capital Partners , Business Angels Des Grandes Ecoles , Seventure Partners , Founding Chairman , Fournier Majoie Foundation , Anaxago Venture Capital , Venture Capital ,

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Czech Republic , France General , Laboratoires Fournier , Bernard Majoie , Antoine Prestat , Gustave Roussy , Sylvie Berrebi , Institut Curie , Gaston Vasseur , Seed Fund , Sorbonne University , Fournier Majoie Foundation For Innovation , Bpifrance This , Cell Penetrating , Interfering Peptide , Investment Manager , Fonds Unique Interminist , Interfering Peptides , Italian Angels , Magna Capital Partners , Business Angels Des Grandes Ecoles , Seventure Partners , Founding Chairman , Fournier Majoie Foundation , Anaxago Venture Capital , Venture Capital ,